Literature DB >> 19274383

Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease.

Daniela A D'Avila1, Paulo M M Guedes, Ana M Castro, Eliane D Gontijo, Egler Chiari, Lúcia M C Galvão.   

Abstract

The immune response is crucial for protection against disease; however, immunological imbalances can lead to heart and digestive tract lesions in chagasic patients. Several studies have evaluated the cellular and humoral immune responses in chagasic patients in an attempt to correlate immunological findings with clinical forms of Chagas disease. Moreover, immunoglobulins and cytokines are important for parasitic control and are involved in lesion genesis. Here, cytokine and IgG isotype production were studied, using total epimastigote antigen on sera of chagasic patients with indeterminate (IND, n = 27) and cardiac (CARD, n = 16) forms of the disease. Samples from normal,uninfected individuals (NI, n = 30) were use as controls. The results showed that sera from both IND and CARD patients contained higher levels of Trypanosoma cruzi-specific IgG1 (IgG1) antibodies than sera from NI. No difference in IgG2 production levels was observed between NI, IND and CARD patients, nor was a difference in IL-10 and IFN-gamma production detected in the sera of IND, CARD and NI patients. However, IND patients displayed a positive correlation between IL-10 and IFN-gamma levels in serum, while CARD patients showed no such correlation, indicating an uncontrolled inflammatory response in CARD patients. These findings support the hypothesis that a lack of efficient regulation between IFN-gamma and IL-10 productions in CARD patients may lead to cardiac immunopathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274383     DOI: 10.1590/s0074-02762009000100015

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  13 in total

1.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 2.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

3.  Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.

Authors:  Paulo Marcos Matta Guedes; Fredy Roberto Salazar Gutierrez; Grace Kelly Silva; Renata Dellalibera-Joviliano; Gerson Jhonatan Rodrigues; Lusiane Maria Bendhack; Anis Rassi; Anis Rassi; André Schmidt; Benedito Carlos Maciel; José Antonio Marin Neto; João Santana Silva
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 4.  Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Authors:  Maria-Jesus Pinazo; Maria-Carmen Thomas; Juan Bustamante; Igor Correia de Almeida; Manuel-Carlos Lopez; Joaquim Gascon
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04-28       Impact factor: 2.743

5.  Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).

Authors:  Cristina Poveda; Manuel Fresno; Núria Gironès; Olindo A Martins-Filho; Juan David Ramírez; Julien Santi-Rocca; José A Marin-Neto; Carlos A Morillo; Fernando Rosas; Felipe Guhl
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

6.  Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load.

Authors:  Bruna Perez Vazquez; Thaís Perez Vazquez; Camila Botelho Miguel; Wellington Francisco Rodrigues; Maria Tays Mendes; Carlo José Freire de Oliveira; Javier Emílio Lazo Chica
Journal:  Parasit Vectors       Date:  2015-04-03       Impact factor: 3.876

7.  Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation.

Authors:  Tiago Silva Medina; Gabriela Gonçalves Oliveira; Maria Cláudia Silva; Bruna Araújo David; Grace Kelly Silva; Denise Morais Fonseca; Renata Sesti-Costa; Amanda Farage Frade; Monique Andrade Baron; Barbara Ianni; Alexandre Costa Pereira; Christophe Chevillard; Edécio Cunha-Neto; José Antonio Marin-Neto; João Santana Silva
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

8.  IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment.

Authors:  Maurício Llaguno; Marcos Vinícius da Silva; Fernanda Rodrigues Helmo; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Acta Parasitol       Date:  2021-06-11       Impact factor: 1.440

Review 9.  Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes.

Authors:  Christiane Maria Ayo; Márcia Machado de Oliveira Dalalio; Jeane Eliete Laguila Visentainer; Pâmela Guimarães Reis; Emília Ângela Sippert; Luciana Ribeiro Jarduli; Hugo Vicentin Alves; Ana Maria Sell
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

10.  The role of fat on cardiomyopathy outcome in mouse models of chronic Trypanosoma cruzi infection.

Authors:  Paul Zaki; Elisa Lbc Domingues; Farhad M Amjad; Maiara B Narde; Karolina R Gonçalves; Mirelle L Viana; Heberth de Paula; Wanderson G de Lima; Huan Huang; Maria T Bahia; Philipp E Sherer; Fabiane M Dos Santos; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2020-03-24       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.